Applications are currently being accepted for the Pfizer - Grants for AI-Enabled COVID-19 Treatment Research 2026. Interested applicants are encouraged to click here to learn more about this opportunity and apply for it.
About Pfizer - Grants for AI-Enabled COVID-19 Treatment Research
The programme focuses on improving access to antiviral treatment, identifying eligible high-risk patients, managing drug–drug interactions, and supporting evidence-based COVID-19 care using AI-driven healthcare solutions.
Benefits of Pfizer - Grants for AI-Enabled COVID-19 Treatment Research
- Maximum funding available: Up to $500,000 USD per project
Pfizer - Grants for AI-Enabled COVID-19 Treatment Research Requirements
- The institution and Principal Investigator (PI) must be based in one of the eligible countries noted above.
- Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society).
- If the project involves multiple departments within an institution and/or between different institutions / organizations / associations, all institutions must have a relevant role and the requesting organization must have a key role in the project.
- The PI must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work.
- The applicant must be the PI or an authorized designee of such individual (e.g., PI’s research coordinator).
- The PI must be an employee or contractor of the requesting organization.
- Requesting organization must be legally able to receive award funding directly from Pfizer Inc.. We strongly recommend that applicants confirm this with their organization or institution prior to submitting an application. Grants awarded to organizations that are subsequently found to be unable to accept funding directly from Pfizer Inc. may be subject to rescission.
- Geographic Scope: Australia, Canada, China, Germany, Greece, Japan, Korea, Taiwan
Application Date and Process
- Click on the link to the application website to apply.
Application Deadline
07 July, 2026
Opportunity Application
View details of
Pfizer - Grants for AI-Enabled COVID-19 Treatment Research
Apply for Pfizer - Grants for AI-Enabled COVID-19 Treatment Research
🔍
